Polymeric and lipid nanoparticles in self-amplifying RNA vaccines result in higher protein expressio …

polymeric and lipid nanoparticles in self amplifying rna vaccines result in higher protein expression and immunogenicity

Sumary of Polymeric and lipid nanoparticles in self-amplifying RNA vaccines result in higher protein expression and immunogenicity:

  • Thanks to its self-amplification properties, much lower doses (typically 100-fold lower) of saRNA are sufficient for vaccine production compared to messenger RNA (mRNA).
  • saRNA, being a versatile platform, can be used to generate vaccines against any pathogen with a known protein target, including influenza, chlamydia, HIV-1, Ebola, and RSV.
  • First-in-human clinical trial against SARS-CoV-2 to test the potency and scalability of the saRNA technology The potential of saRNA was recently tested for the first time in humans in a combined Phase I/II clinical trial against SARS-CoV-2. The study demonstrated the potency and scalability of the saRNA technology.
  • ” The researchers first compared the in vivo protein expression of saRNA formulated with pABOL and several LNP formulations.
  • They then compared the matching formulations with saRNA encoding the influenza hemagglutinin (HA) glycoprotein as a model antigen to assess differences in immunogenicity.
  • They also investigated the dose-response curve for LNP against the SARS-CoV-2 spike glycoprotein protein antigen and compared intramuscular (IM) and intranasal (IN) routes of administration.
  • pABOL-formulated saRNA resulted in higher protein expression, while LNP formulations improved immunogenicity The researchers observed that pABOL-formulated saRNA led to higher protein expression, but the LNP formulations were more immunogenic.
  • IN administration of LNP affected vaccine immunogenicity of 2 model antigens – HA and SARS-CoV-2 spike protein.

Want to know more click here go to source.

From -

Close

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close